Black Diamond Therapeutics BDTX 深 沪
等待开盘 08-15 09:30:00 美东时间
2.79
+0.020
+0.72%
华盛通- 最 高2.84
- 今 开2.72
- 成交量 107.91万股
- 最 低 2.6917
- 昨 收 2.77
- 总市值 1.59亿
- 52周最高 6.645
- 市盈率 静 --
- 换手率 1.90%
- 52周最低 1.195
- 委 比 -33.72%
- 总股本 5686.26万
- 历史最高 46.25
- 量 比 0.81
- 振 幅 5.35%
- 历史最低 1.18
- 每 手 1
- 风险率 1.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Black Diamond Group reports Q2 results
Black Diamond Group press release (OTCQX:BDIMF): Q2 profit of C$9.2 million increased 23% from the comparative quarter. Basic earnings per share of C$0.15 increased 25% from the comparative quarter. C...
08-08 15:57
Black Diamond Gr Q2 EPS $0.15 Beats $0.14 Estimate, Sales $105.400M Beat $97.977M Estimate
Black Diamond Gr (TSX:BDI) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.14 by 7.14 percent. This is a 25 percent increase over earnings of $0.12 per share from the same
08-08 06:49
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
- Black Diamond Therapeutics completed enrollment of 43 patients in the Phase 2 trial of silevertinib for non-classical EGFRm NSCLC and expects ORR and DOR data in Q4 2025. - The company is exploring partnerships to advance silevertinib in NSCLC and GBM. - Black Diamond plans to meet with the FDA in 1H 2026 to discuss a potential registrational path for silevertinib in NSCLC, contingent on PFS data availability. - Cash, cash equivalents, an...
08-07 11:30
Make Dinnertime Fresh Together
Retailer brings the family together in the kitchen CINCINNATI, Aug. 5, 2025 /PRNewswire/ -- The Kroger Co. (NYSE: KR) today shared easy tips to make a fresh family meal together, centered ar...
08-05 21:30
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Raymond James Reinstates Outperform on Black Diamond Therapeutic, Announces $11 Price Target
Raymond James analyst Sean McCutcheon reinstates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and announces $11 price target.
07-01 23:39
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
Black Diamond Therapeutics' CEO, Mark Velleca, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4, 2025 in New York. The company will also host investor meetings and provide a webcast of the presentation on its investor relations website, available for 90 days post-event. BDTX is advancing a Phase 2 trial of its brain-penetrant EGFR MasterKey inhibitor, BDTX-1535, targeting EGFR-mutant NSCLC and glioblasto...
05-29 12:00
Black Diamond Therapeutic Q1 EPS $0.98 Beats $0.02 Estimate, Sales $70.00M
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.02 by 4800 percent. This is a 380 percent increase over losses of $(0.35) per share
05-13 04:38
What Analysts Are Saying About Clarus Stock
Clarus (NASDAQ:CLAR) has been analyzed by 4 analysts in the last three months, ...
05-10 04:01
Black Diamond Group to conduct normal course issuer bid
Black Diamond Group (OTCQX:BDIMF) said the Toronto Stock Exchange has approved its intention to renew its normal course issuer bid. The bid will start on May 12, and in the 12-month period, the firm c...
05-08 20:29
